Home > Boards > US OTC > Medical - Healthcare > InVivo Therapeutics Holdings Corp (NVIV)

This stock is currently 1/100+ from where it

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Devo33 Member Profile
 
Followed By 5
Posts 413
Boards Moderated 0
Alias Born 10/16/14
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2019 4:30:59 PM
InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord Business Wire - 7/16/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/12/2019 8:12:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/12/2019 8:06:17 AM
InVivo Therapeutics Announces Postponement of Annual Meeting Business Wire - 7/12/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/5/2019 8:01:02 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/1/2019 6:00:53 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/21/2019 4:08:00 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 6/21/2019 8:02:13 AM
InVivo Therapeutics gibt Vertagung der Hauptversammlung bekannt Business Wire - 6/14/2019 1:21:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 8:06:21 AM
InVivo Therapeutics Announces Adjournment of Annual Meeting Business Wire - 6/14/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/14/2019 7:51:21 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:10:45 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:07:49 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/30/2019 6:01:28 AM
InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal C... Business Wire - 5/29/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/22/2019 5:56:59 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 5/17/2019 4:37:53 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 8:03:06 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/25/2019 5:22:49 PM
InVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal... Business Wire - 4/17/2019 8:00:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/15/2019 5:14:37 PM
InVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business Update Business Wire - 4/1/2019 8:15:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/1/2019 8:10:25 AM
Devo33   Sunday, 07/15/18 02:52:15 PM
Re: DDobserver post# 6061
Post # of 6120 
This stock is currently 1/100+ from where it was a year and a half ago when success was being achieved. We all know the NSS represents the best acute SCI treatment available today. The Inspire study didn't fail the benefit standard in that there were numerous patients that benefited significantly. The safety standard however was not achieved. Clearly the NSS was not the obvious cause of the deaths or the FDA would not have authorized the 2.0. But any safety issues need to be figured out and that takes time to minimize risk going forward, Its not surprising we are still waiting for the first implant of 2.0. The money is available. The hospitals are still ready. Patients are available. The benefit has been clearly documented.....but so has the risk. If the numbers are correct, I am glad to see that the Institutional owner % is still quite high. 100X ROI by next summer! I know thats way too long for most of the posters on this board, You and I have been around for a long time and I still believe in the science, the inventors, and the benefit. Management is an unknown. I will stick around and see what happens, Should be plenty of trading volatility over the next year.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist